Trial · NCT03774082
Participant flow24
How many started, completed or left each group, period by period.
1 to 20 of 24
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | ≥ 12y - < 18y RUX 10mg BID (Group 1) | 22 | |
| Overall Study | STARTED | ≥ 6y - < 12y RUX 5mg BID (Group 2) | 17 | |
| Overall Study | STARTED | ≥ 2y - < 6y RUX 4mg/m2 BID (Group 3) | 7 | |
| Overall Study | Full Analysis Set | ≥ 12y - < 18y RUX 10mg BID (Group 1) | 22 | |
| Overall Study | Full Analysis Set | ≥ 6y - < 12y RUX 5mg BID (Group 2) | 16 | |
| Overall Study | Full Analysis Set | ≥ 2y - < 6y RUX 4mg/m2 BID (Group 3) | 7 | |
| Overall Study | Completed Treatment | ≥ 12y - < 18y RUX 10mg BID (Group 1) | 3 | |
| Overall Study | Completed Treatment | ≥ 6y - < 12y RUX 5mg BID (Group 2) | 5 | |
| Overall Study | Completed Treatment | ≥ 2y - < 6y RUX 4mg/m2 BID (Group 3) | 3 | |
| Overall Study | Discontinued From Treatment | ≥ 12y - < 18y RUX 10mg BID (Group 1) | 19 | |
| Overall Study | Discontinued From Treatment | ≥ 6y - < 12y RUX 5mg BID (Group 2) | 11 | |
| Overall Study | Discontinued From Treatment | ≥ 2y - < 6y RUX 4mg/m2 BID (Group 3) | 4 | |
| Overall Study | Participants Who Received Tablets | ≥ 12y - < 18y RUX 10mg BID (Group 1) | 22 | |
| Overall Study | Participants Who Received Tablets | ≥ 6y - < 12y RUX 5mg BID (Group 2) | 14 | |
| Overall Study | Participants Who Received Tablets | ≥ 2y - < 6y RUX 4mg/m2 BID (Group 3) | 0 | |
| Overall Study | Participants Who Received Liquid | ≥ 12y - < 18y RUX 10mg BID (Group 1) | 0 | |
| Overall Study | Participants Who Received Liquid | ≥ 6y - < 12y RUX 5mg BID (Group 2) | 2 | |
| Overall Study | Participants Who Received Liquid | ≥ 2y - < 6y RUX 4mg/m2 BID (Group 3) | 7 | |
| Overall Study | COMPLETED | ≥ 12y - < 18y RUX 10mg BID (Group 1) | 14 | |
| Overall Study | COMPLETED | ≥ 6y - < 12y RUX 5mg BID (Group 2) | 10 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03774082/flow